Back to Top
Go Back
Journal Photo for OncoImmunology
Peer reviewed only Open Access

OncoImmunology (OncoImmunology)

Publisher : Taylor & Francis
Basic and translational studies Modern immunotherapies Inflammation
e-ISSN 2162-402X
Issue Frequency Continuously
Impact Factor 6.5
Est. Year 2012
Mobile 4402080520500
DOI YES
Country United Kingdom
Language English
APC YES
Impact Factor Assignee GOOGLE SCHOLAR
Email enquiries@taylorandfrancis.com

Journal Descriptions

OncoImmunology is a dynamic, high-profile, open access journal broadly covering tumor immunology and immunotherapy. As cancer immunotherapy continues to evolve, OncoImmunology aims to publish high-quality, rigorous research on all aspects of basic and applied tumor immunology. Topics covered include: Basic and translational studies in immunology of both solid and hematological malignancies Inflammation, innate and acquired immune responses against cancer Mechanisms of cancer immunoediting and immune evasion Modern immunotherapies including, but not limited to, immunomodulators, immune checkpoint inhibitors, T-cell, NK-cell and macrophage engagers, and CAR T cells Immunological effects of conventional anticancer therapies. OncoImmunology operates a single-anonymized peer review policy.

OncoImmunology (OncoImmunology) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Basic and translational studies, Modern immunotherapies, Inflammation, innate, acquired immune responses against cancer, macrophage engagers, immunomodulators, immune checkpoint inhibitors, T-cell, NK-cell , Online , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2162-402X, Established: 2012, Impact Factor: 6.5
  • Provides Crossref DOI
  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing